amifostine anhydrous has been researched along with Bone Diseases in 3 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Bone Diseases: Diseases of BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Irradiated animals received a fractionated dosing schedule of 35 Gy, with amifostine-pretreated animals receiving amifostine before irradiation." | 1.40 | Prophylactic amifostine preserves the biomechanical properties of irradiated bone in the murine mandible. ( Ahsan, S; Buchman, SR; Deshpande, SS; Donneys, A; Felice, PA; Kozloff, KM; Nelson, NS; Perosky, JE, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felice, PA | 1 |
| Ahsan, S | 1 |
| Perosky, JE | 2 |
| Deshpande, SS | 2 |
| Nelson, NS | 2 |
| Donneys, A | 2 |
| Kozloff, KM | 2 |
| Buchman, SR | 2 |
| Fearon, JA | 1 |
| Polyatskaya, Y | 1 |
| Rodriguez, JJ | 1 |
| Figueredo, C | 1 |
| Vasseli, CA | 1 |
| Ratliff, HC | 1 |
3 other studies available for amifostine anhydrous and Bone Diseases
| Article | Year |
|---|---|
Prophylactic amifostine preserves the biomechanical properties of irradiated bone in the murine mandible.
Topics: Amifostine; Animals; Biomechanical Phenomena; Bone Diseases; Chemoprevention; Dose Fractionation, Ra | 2014 |
Discussion: Prophylactic amifostine preserves the biomechanical properties of irradiated bone in the murine mandible.
Topics: Amifostine; Animals; Bone Diseases; Male; Mandible; Radiation Injuries, Experimental; Radiation-Prot | 2014 |
Prevention of radiation-induced bone pathology through combined pharmacologic cytoprotection and angiogenic stimulation.
Topics: Amifostine; Angiography; Animals; Biomechanical Phenomena; Bone Density; Bone Diseases; Cytoprotecti | 2016 |